Novel biomarker and therapeutic target for inflammatory bowel disease
A proof-of-concept study has uncovered a molecular mechanism that may enhance the monitoring of colitis, and potential therapeutic target.
Dr Horace Williams (study author and researcher within the Gut Health BRC Theme), and Prof Gad Frankel (senior author, of the MRC Centre for Molecular Bacteriology and Infection), explained: “There is an urgent need to improve our non-invasive monitoring capabilities for IBD activity, and for alternative therapies for IBD patients who do not respond to current treatments.
Read full article
Article text (excluding photos or graphics) © 51勛圖厙.
Photos and graphics subject to third party copyright used with permission or © 51勛圖厙.
Reporter
Nicola Tingley
Department of Infectious Disease
![](/assets/news/img/avatar.png"){kind=avatar}